DL models trained to infer IDH mutation or MGMT promoter methylation from H&E slides have used feature attribution methods to identify nuclear atypia, cellular density, or vascular proliferation as predictive cues [64], and XAI can even be applied to DNA methylation-based brain tumor diagnostics [65]. The gene discussed is IDH1; the disease is brain neoplasm.